SIL-204 administered in an extended release formulation reduced tumor growth by ~50% after 30 days, with ~50% of tumors ...

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...

GI Innovation (KQ:358570) announced that it signed a Memorandum of Understanding (MOU) with LaNova Medicines (LaNova) for the ...

Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.

Google has released its first major update to the Search Quality Rater Guidelines since March. Human evaluators use the ...

The Elizabethtown Area High School community is mourning the loss of a larger-than-life figure who modeled perseverance, ...

Revolution Medicines, Inc. (NASDAQ:RVMD), a biotechnology company focused on developing novel therapies for RAS-dependent cancers, has been garnering significant attention from analysts and investors ...

Mama’s life was a testament to resilience. Despite her hardships, she exuded warmth, dignity, and kindness. She taught me to ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

Cordance Medical, a pioneer in non-invasive medical technologies for brain disease treatment, and EXACT Therapeutics (Euronext Growth: EXTX), a clinical-stage precision medicine company, are pleased ...

Abbie Stockard declared victory over 51 other contestants. She credited her relationship with God for giving her the drive to ...